Medi-Tate medi-tate.com


Public lists: Medical Devices (6123)

Medi-Tate, headquartered in Akiva, Israel, is an Israeli medical device company focused on research, development, manufacture and sale of solutions for the treatment of Benign Prostatic Hyperplasia (BPH). Medi-Tate has developed iTind, a minimally invasive procedure to treat the symptoms of enlarged prostate in men whose primary other treatment options would be pharmaceutical therapy or surgery. The iTind procedure uses a 5 day implant to reshape the prostatic urethra and create new channels thr...Show all

Medi-Tate, headquartered in Akiva, Israel, is an Israeli medical device company focused on research, development, manufacture and sale of solutions for the treatment of Benign Prostatic Hyperplasia (BPH). Medi-Tate has developed iTind, a minimally in...Show all

Company (Alive / Active)

Phone: +972-77-700-6745

Fax:

9 HaHadas Street

Or Akiva,
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Medi-Tate $24M Nov 5, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Medi-Tate Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Alsius Corporation

Chelmsford, Massachusetts, United States
AcquiredALSIUS is a provider of advanced patient temperature management therapies. Alsius Intravascular Temperature Management gives health care providers the power and control they need to rapidly, safely, and effectively manage the core body temperature of critically ill or surgical patients. Alsius has been acquired by a wholly-owned subsidiary of ZOLL Medical Corporation. (Nasdaq:ZOLL).Login to see details

EnteroMedics

St Paul, Minnesota, United States
IPO / Went publicEnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a first-in-class weight loss treatment that addresses the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension. vBloc® Therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System controls both hunger and fullness by bloc...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Radial cutter implant Dec 22, 2009 Dec 26, 2017 Patent
Device for dilating the urethra of the body of a patient and device for removing prostate tissue May 07, 2008 Dec 10, 2013 Patent
Radial cutter implant Oct 12, 2017 Application
An incising implant for the prostatic urethra Dec 02, 2014 Application